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Abstract
Background: Genomic methylation patterns are established during gametogenesis, and perpetuated in somatic
cells by faithful maintenance methylation. There have been previous indications that genomic methylation patterns
may be less stable in embryonic stem (ES) cells than in differentiated somatic cells, but it is not known whether
different mechanisms of de novo and maintenance methylation operate in pluripotent stem cells compared with
differentiating somatic cells.
Results: In this paper, we show that ablation of the DNA methyltransferase regulator DNMT3L (DNA
methyltransferase 3-like) in mouse ES cells renders them essentially incapable of de novo methylation of newly
integrated retroviral DNA. We also show that ES cells lacking DNMT3L lose DNA methylation over time in culture,
suggesting that DNA methylation in ES cells is the result of dynamic loss and gain of DNA methylation. We found
that wild-type female ES cells lose DNA methylation at a much faster rate than do male ES cells; this defect could
not be attributed to sex-specific differences in expression of DNMT3L or of any DNA methyltransferase. We also
found that human ES and induced pluripotent stem cell lines showed marked but variable loss of methylation that
could not be attributed to sex chromosome constitution or time in culture.
Conclusions: These data indicate that DNA methylation in pluripotent stem cells is much more dynamic and error-
prone than is maintenance methylation in differentiated cells. DNA methylation requires DNMT3L in stem cells, but
DNMT3L is not expressed in differentiating somatic cells. Error-prone maintenance methylation will introduce
unpredictable phenotypic variation into clonal populations of pluripotent stem cells, and this variation is likely to
be much more pronounced in cultured female cells. This epigenetic variability has obvious negative implications
for the clinical applications of stem cells.
Background
De novo DNA methylation occurs primarily in non-
dividing germ cells in a sexually dimorphic manner [1].
Ak e yr e g u l a t o ro fde novo methylation is the DNA
methylation cofactor/adaptor DNMT3L (DNA methyl-
transferase 3-like). Genetic studies show that DNMT3L
is required for the establishment of genomic imprints
in growing oocytes [2] and for de novo methylation at
retrotransposons in prospermatogonia [3]. Although
DNMT3L possesses the structural folds present in all
catalytically active mammalian DNA methyltransferases
[4], it lacks the functional domains required for catalytic
activity, and is unable on its own to cause DNA methy-
lation [5]. Biochemical studies have demonstrated that
DNMT3L can function as a regulator of the DNA
methyltransferases DNMT3A and DNMT3B [6].
DNMT3L is not expressed in differentiated somatic cells
but is expressed in embryonic stem (ES) cells, which are
known to be highly active in DNA methylation [7,8].
We previously showed that DNMT3L forms a complex
with DNMT3A2 and DNMT3B, and that this complex
specifically binds to nucleosomes that are unmethylated
at lysine 4 of histone H3 (H3K4) [4]. Biochemical stu-
dies revealed that DNMT3L interacts via the N-terminal
cysteine-rich region with the N terminal tail of histone
H3, and that this interaction is abolished by di- or tri-
methylation of H3K4. This resulted in the postulation of
the DNMT3L histone recognition hypothesis, which
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sequences is dependent on the ability of DNMT3L to
bind the histone H3 N-terminus and that regulation of
H3K4 methylation plays a role in targeted de novo DNA
methylation. It is interesting to note that genomewide
analysis of DNA methylation and H3K4 methylation,
particularly di- and tri-methylation, reveals a mutually
exclusive distribution [9], supporting the notion that
H3K4 methylation protects promoter regions from
de novo methylation.
Maintenance methylation is very stable in differen-
tiated/somatic cells, and DNA that is methylated in pre-
determined patterns maintains this methylation pattern
for >80 cell divisions in transfected cells [10]. This stabi-
lity is a consequence of recognition of hemimethylated
DNA after DNA replication by DNMT1 and the regula-
tory factor UHRF1 (ubiquitin-like, containing PHD and
RING finger domains 1) [11]. Both DNMT1 and
UHRF1 bind to hemimethylated CpG dinucleotides, and
deficiency in either factor results in genomewide
demethylation and embryonic lethality [12-14].
Additional mechanisms are likely to be involved in the
correct recruitment of both DNMT1 and UHRF1. The
observation that UHRF1 is able to bind to histone H3
that is di- or trimethylated at lysine 9 [15] implies the
involvement of other chromatin factors.
Mitotic inheritance of genomic methylation patterns
has been reported to be less faithful in ES cells than in
differentiated somatic cells. A study of imprinted loci by
Dean et al. [16] and Humphreys et al. [17] reported that
methylation imprints are gained and lost at high rates in
clonal populations of ES cells, although the mechanism
of this was not apparent. Zvetkova et al.[ 1 8 ]r e p o r t e d
spontaneous loss of methylation at imprinted and repeat
sequences specifically in female ES cells; this was attrib-
uted to lower levels of DNMT3A/DNMT3B in XX cells.
We report here that mouse ES cells that lack
DNMT3L lose methylation during culture, unlike non-
stem cells, which maintain methylation patterns in the
absence of DNMT3L. Loss of DNA methylation is much
more rapid in female than in male mutant ES cells, even
though levels of DNA methyltransferases and DNMT3L
are the same in male and female ES cells. We also
found that human ES and induced pluripotent stem
(iPS) cells tend to lose DNA methylation spontaneously
in a process that is independent of sex and passage
number. Whereas maintenance methylation in non-stem
cells is mediated by the faithful copying of methylation
patterns at S phase, stem cell-specific maintenance of
genomic methylation patterns involves dynamic
demethylation and de novo methylation, which leads to
heterogeneous methylation within clonal cell popula-
tions. This instability has the potential to cause dysregu-
lation of imprinted genes and other gene expression
abnormalities. Epigenetic instability is likely to introduce
unpredictable phenotypic variation into clonal popula-
tions of ES and iPS cells, and the effect will be more
severe when the cells are female.
Results
Previous studies have demonstrated a requirement for
DNMT3A and DNMT3B in the establishment of methy-
lation in newly integrated Moloney murine leukemia
virus (Mo-MLV) in ES cells [19]. We determined whether
the regulatory factor DNMT3L was also required for this
process. To allow the specific detection of the newly inte-
grated retrovirus from the many copies endogenous to
the mouse genome, we generated a Mo-MLV carrying an
arbitrary 42 bp insertion within the U3 region of the long
terminal repeat (LTR), (Mo-MLV
42bp/GFP)( F i g u r e1 a ) .
The retroviral construct was further rendered resistant to
TRIM28-ZFP809 mediated-restriction [19,20] by replace-
ment of the transfer (t)RNA
Pro primer binding site (PBS)
with a tRNA
Gln PBS. This made the provirus largely
resistant to TRIM28-ZFP809-dependent transcriptional
silencing (Figure 1b). However, infection of wild-type ES
cells resulted in the gradual silencing of proviral expres-
sion during passage. Ablation of DNMT3L largely pre-
vented the passage-dependent silencing of retroviral
transcription that occurs in the presence of DNMT3L,
and this lack of silencing activity was associated with a
failure to methylate the LTRs of the Mo-MLV
42bp/GFP
retrovirus (Figure 1c).
It was surprising to find that female (XX) ES cells
were much less proficient at provirus methylation than
were male (XY) ES cells (Figure 1d), both in the pre-
sence and absence of DNMT3L. Also surprising was the
DNMT3L-independent de novo methylation of the Oct4
promoter (Figure 1e), which normally occurs when ES
cells are induced to differentiate [20]. However, there
are both DNMT3L-dependent and -independent
de novo methylation events in germ cells [2,3].
As shown in Figure 2a, DNMT3L is required for the
maintenance of genomic methylation patterns in ES
cells. DNMT3L is not required for maintenance methy-
lation in somatic cells, as it is not expressed in differen-
tiated somatic cells, and ablation of DNMT3L results in
normal DNA methylation and normal mouse develop-
ment [1]. Both Dnmt3L
-/- and Dnmt3
+/+ XX ES cells
lost methylation at much higher rates than did XY ES
cells (Figure 2b). All eight independent XX ES cell lines
tested showed much greater loss of methylation than
did the three XY cell lines tested (Figure 2c).
It had been previously reported that wild-type XX ES
cells lose methylation with continued passage in culture,
with reduced expression of both DNMT3A and DNMT3B
in XX cells being reported as the cause [18]. However, our
quantitative immunoblot analysis (Odyssey® Infrared
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Page 2 of 10Figure 1 De novo methylation of proviral DNA requires DNMT3L (DNA methyltransferase 3-like). (a) Retrovirus reporter
construct with long terminal repeats (LTRs) modified to allow identification of reporter provirus against background of endogenous retroviruses.
(b) Replacement of primer binding site relieved TRIM28-ZFP809 mediated silencing, and the primer binding site was changed to be
complementary to glutamine (Q) transfer (t)RNA. (c) Embryonic stem (ES) cells lacking DNMT3L were unable to silence the retrovirus shown in
(a). Green fluorescent protein (GFP)-expressing cells were isolated by flow sorting 3 days post-infection (dpi), and GFP expression was monitored
by fluorescence-activated cell sorting over the time period indicated. (d) Lack of retrovirus silencing accompanied lack of LTR methylation.
(e) Wild-type female ES cells were inefficient in de novo methylation, and methylation defect in female ES cells was seen in wild-type cells but
was more severe in Dnmt3L
-/- ES cells. (f) De novo methylation of Oct4 5’ region was not affected by loss of DNMT3L. All P values were obtained
by the non-parametric two-tailed Mann-Whitney test.
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USA) showed that levels of DNMT1, DNMT3A,
DNMT3B and DNMT3L were very similar in XX and XY
ES cells (Figure 3a-c), and that their levels were very simi-
lar in early and late passage ES cells (Figure 3a, b). The
numerous isoforms of DNMT3B that arise via alternative
splicing were also very similar in XX and XY ES cells (Fig-
ure 3a, b). These data indicate that the cause of XX-speci-
fic demethylation is not reduced expression of DNA
methyltransferases.
The finding that DNMT3L is required for de novo
methylation of retroviral DNA allowed us to test the
importance of the interaction of DNMT3L with
unmethylated H3K4. Mutations that caused amino acid
substitutions at positions necessary for the interaction of
DNMT3L and histone H3 [4] were introduced into
DNMT3L expression constructs and stably expressed in
ES cells. The recombinant proteins were stable and were
expressed at levels equal to or greater than that of endo-
genous DNMT3L or of transfected wild-type DNMT3L
Figure 2 Time- and sex-dependent loss of DNA methylation in absence of DNMT3L (DNA methyltransferase 3-like). All embryonic stem
(ES) cell clones analyzed had typical ES cell morphology and comparable growth rates (data not shown). (a) Culture of Dnmt3L
-/- ES cells caused
a loss of DNA methylation from multiple repeat-sequence classes. LINE1 promoters, Intracisternal A Particle (IAP) long terminal repeats (LTRs) and
minor satellite are shown. (b) Loss of methylation in XX Dnmt3L
-/- ES cells was more rapid than in XY Dnmt3L
-/- ES cells. Late passage XX
Dnmt3L
-/- ES cells showed an extent of demethylation that was similar to that of ES cells null for Dnmt1. Dnmt3L genotype is indicated by ‘+/+’
and ‘-/-’ at the top of each lane. (c) Comparison of DNA methylation in XY and XX ES cells. Three normal XY ES cell lines were compared with
eight normal XX ES cell lines. Demethylation was more pronounced in all of the XX lines compared with XY cells.
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Page 4 of 10(Figure 4a). Disruption of the DNMT3L-H3K4 interac-
tion caused a partial reduction of methylation in the
c a s eo ft h eD 1 2 4 As u b s t i t u t i o na n das e v e r er e d u c t i o n
in de novo methylation in the case of the I141W muta-
tion (Figure 4b). These data indicate that the bulk of de
novo methylation mediated by DNMT3L is probably
regulated by the association of unmethylated DNA with
nucleosomes that are enriched in unmethylated H3K4.
The finding that mouse ES cells display sex-specific
epigenetic instability suggested that human ES and iPS
cells might show a similar instability. Human ES and
iPS lines were tested for loss of methylation at LINE1
transposon promoters, a-satellite DNA, satellite 2 DNA
from chromosomes 1 and 16, and satellite 3 DNA from
chromosome 9. All human ES and iPS lines showed loss
of methylation at a-satellite DNA, and two human ES
lines and two iPS lines showed marked demethylation of
satellite 3 and LINE1 promoters; satellite 2 was not
affected in any cell line (Figure 5). Demethylation was
not strongly associated with passage history or sex chro-
mosome constitution, and the N1 and D10 iPS lines
showed greater demethylation at early than at later pas-
sages. These data indicate that human ES and iPS cells
are subject to marked epigenetic instability under condi-
tions of normal ex vivo propagation.
Discussion
ES and embryonic carcinoma cells are known for their
ability to potently restrict retroviral expression [7,8],
which involves two phases. The initial phase, which
immediately follows retroviral integration, depends on
the interaction of retroviral DNA sequences with host
restriction factors, which include TRIM28 [21] and
ZFP809 [22]. Maintenance of this repression is subse-
quently thought to rely on epigenetic mechanisms, pri-
marily DNA methylation. Clonal studies in ES cells
using murine stem cell virus (MSCV) transduction fol-
lowed by knockdown of DNMT3A and/or DNMT3B
showed that maintenance of DNA methylation is impor-
tant for stable proviral silencing [23], and 5-azacytidine-
induced demethylation of previously methylated and
silent MSCV provirus resulted in their reactivation [24].
Both these observations suggest that DNA methylation
is necessary to enforce provirus silencing. By starting
with a population of ES cells in which integrated pro-
virus has escaped the initial silencing system by virtue
of replacement of the primer binding site to prevent
binding of ZFP809, we investigated the role of
DNMT3L-mediated DNA methylation acquisition in the
gradual silencing of active retrovirus. We found that the
ability to silence over time is dependent on the ability to
acquire methylation at proviral LTRs.
Whereas DNMT3L was found to be necessary for de
novo methylation of newly integrated proviral DNA, it
was dispensable for de novo methylation at a promoter
after induction of differentiation. In vitro differentiation
of ES cells is known to coincide with de novo methyla-
tion at over 300 CpG-poor regions that are in proximity
to gene promoters [25]. This is evidence of DNMT3L-
Figure 3 Normal expression of DNA methyltransferase (DNMT)
1, DNMT3A, DNMT3B and DNA methyltransferase 3-like
(DNMT3L) in XY and XX embryonic stem (ES) cells.( a) All three
DNMTs and DNMT3L were expressed at similar levels regardless of
passage history or sex chromosome substitution. (b) Comparison of
a panel of eight XX and three XY ES cell lines showed similar
expression of DNMT3A and DNMT3B. (c) Quantification of DNMT3A
and DNMT3B expression. Signal intensities were measured by an
imaging system as described in the text, and normalized against
tubulin. The data showed that that XY and XX ES cells had very
similar levels of DNMT3A and DNMT3B. Error bars indicate one
standard deviation.
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viously reported [2,3]. It is not clear whether the low
density of DNA methylation actually represses transcrip-
tion or whether the de novo methylation of the CpG-
poor Oct4 promoter is actually involved in Oct4
regulation.
Previous studies in mouse ES and iPS cells have
reported that the presence of two X chromosomes
causes genomewide hypomethylation [18,26]. Our quan-
titative studies examined the expression levels of
DNMT1, DNMT3A and DNMT3B in XX and XY ES
cells, and revealed that the increased rate of loss of
Figure 4 DNMT3L (DNA methyltransferase 3-like) that is unable to bind unmethylated H3K4 is deficient in rescue of the de novo
methylation defect in Dnmt3L
-/- embryonic stem (ES) cells. The D90A and I107W substitutions were previously shown to prevent binding of
human DNMT3L to histone H3 peptide unmethylated at lysine position 4 (H3K4) [4]. The equivalent residues in mouse DNMT3L are D124A and
I141W, respectively. (a) The mutant proteins were stable and were expressed at higher levels than the wild-type protein; two independent stable
transfectants are shown for each. (b) Failure of mutant DNMT3L to rescue the de novo methylation defect. The long terminal repeat (LTR) of the
retrovirus shown in Figure 1(a) was tested for de novo methylation at 12 days post-infection. These data demonstrate that de novo methylation
in ES cells requires the interaction of DNMT3L and unmethylated H3K4.
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attributed to reduced amounts of DNA methyltransfer-
ase proteins. It is instead consistent with some inherent
difference between XX and XY ES cells, which affects
DNMT recruitment and general regulation of DNA
methylation. XX cells may have a higher rate of loss of
methylation or a lower rate of remethylation, or both.
The observation that DNMT3L deficiency results in
hypomethylation at retrotransposons and minor satellite
sequences is also in contrast to previously published
results, which claimed that DNMT3L was dispensable
for their methylation [27]. Given that we observed a
passage-dependent effect on the ability to maintain
methylation in the absenceo fD N M T 3 L( F i g u r e2 a ,b ) ,
we propose that this discrepancy might be attributable
to lower passage numbers of the DNMT3L-deficient ES
cells used in the earlier analysis.
Two previous studies reported that the active methyl-
transferases DNMT3A and DNMT3B were required for
methylation content to be maintained at normal levels
[28,29]. Our study is the first to demonstrate that the
catalytically inactive adaptor DNMT3L is required for
normal DNA methylation in pluripotent stem cells.
D N M T 3 Li sn o te x p r e s s e di nd i f f e r e n t i a t e ds o m a t i c
cells, yet unlike Dnmt3L-deficient ES cells, they are able
to maintain genomic methylation patterns with high
fidelity. These findings indicate that methylation pat-
terns in ES cells are the product of the dynamic gain
and loss of DNA methylation, rather than passive clonal
inheritance as occurs in differentiated cells. This places
a higher load on non-maintenance methylation-based
mechanisms, which involve DNMT3 family members.
We speculate that there are at least two possible expla-
nations why maintenance methylation-based mechan-
isms (that is, those involving DNMT1 and UHRF1) are
less effective in ES cells. First, ES cells contain combina-
tions of histone modifications not observed in differen-
tiated somatic cells, which could adversely affect
recruitment of DNMTs and other factors involved in
maintenance methylation. Among these is bivalent
methylation of H3K4 and H3K27, two methylation mar-
kers that are usually mutually exclusive [30]. Although it
has been shown that UHRF1 binds to di- and trimethy-
lated H3K9 [15], the consequences of H3K27 methyla-
tion and of other ES cell-specific patterns of chromatin
modifications are unknown but are likely to be responsi-
ble for some of the epigenetic instability that occurs in
pluripotent stem cells. Second, 5-hydroxymethyl cyto-
sine (hm
5C) is present in DNA of ES cells, [31] and
structural models indicate that UHRF1 cannot bind to
hm
5C[ 3 2 ] .I fh m
5C occurs within CpG dinucleotides,
this could lead to inefficient maintenance methylation.
However, the sequence contexts in which hm
5Co c c u r s
in vivo are not known, and the role of this modified
base in maintenance methylation is unclear.
Conclusions
The most significant feature of unstable genomic methy-
lation patterns in pluripotent stem cells may be the
Figure 5 Instability of genomic methylation patterns in human
embryonic stem (ES) and induced pluripotent stem (iPS) cells.
DNA was analyzed for demethylation at the sequences named on
the left. Controls were the human mammary carcinoma cell line
Hs578T, which has a severely demethylated genome, and the
MDA175 cell line, which is not detectably demethylated. Note that
all human ES and iPS cells showed demethylation of a satellite
relative to MDA175 and that trypsin-passaged H9 and CHB1 human
ES and D10 cells and high-passage 1774-2 iPS cells showed
demethylation of LINE1 promoters and satellite 3 DNA. All human
ES and iPS lines were maintained under the same cell culture
conditions, without the use of trypsin except in the case of the
indicated H9 cell line, for five or more passages.
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nal cell populations, particularly with regard to genome
destabilization, selection of cells that have increased
expression of genes that stimulate cell growth, and the
unpredictable gain and loss of imprinted gene expres-
sion. It should be noted that cultured ES cells are
derived from cell types that exist only transiently
in vivo. Selective pressures for high genetic [33] or epi-
genetic stability are therefore low in vivo.T h ef o r c e d
ex vivo propagation of ES cells for a far greater number
of cell divisions than are undergone by their in vivo
counterparts renders cultured stem cells - both ES and
iPS cells -vulnerable to increased genetic and epigenetic
instability.
Methods
Cell culture and sample preparation
DNMT3L-deficient ES cells were derived from crosses
between Dnmt3L
+/- animals [2] using a previously
described protocol [34]. Dnmt1
-/- and Dnmt3a
-/-;
Dnmt3b
-/- ES cells (generously provided by E. Li, Novar-
tis, MA, USA) have also been described previously [19].
Mouse ES cells were cultured on gelatinized tissue cul-
ture plates in ES cell media (Dulbecco modified Eagle
medium (DMEM) supplemented with 15% fetal bovine
serum, 100 IU/mL penicillin, 100mg/mL streptomycin,
2 mmol/L L-glutamine, MEM non-essential amino
acids, 0.12 mmol/L b-mercaptoethanol, and leukemia
i n h i b i t o r yf a c t o r( L I F )f r o mt h ec o n d i t i o n e dm e d i u mo f
LIF-secreting cells. Human ES and iPS cells were cul-
tured on g-irradiated (CF1-derived) mouse embryonic
fibroblasts (GlobalStem Inc., Rockville, MD, USA) in
standard human ES media (DMEM/F-12; Stem Cell
Technologies Inc., Vancouver, BC, Canada) supplemen-
ted with 20% knockout serum, 1 mM L-glutamine and
100 μM MEM-nonessential amino acids (Invitrogen
Corp., Carlsbad, CA, USA), 100 μM 2-mercaptoethanol
(Sigma Chemical Co., St Louis, MO, USA) and 10ng/ml
recombinant human bFGF (Invitrogen). Both mouse and
human ES and iPS cell DNA was purified using a com-
mercial kit (DNeasy® Blood and Tissue Kit; Qiagen Inc.,
Valencia, CA, USA).
Flow cytometry
For sorting experiments, green fluorescent protein-posi-
tive ES cells were purified on a cell sorter (FACSAria
C e l lS o r t e r ;B DB i o s c i e n c e s ,S a nJ o s e ,C A ,U S A ) ,a n d
analyses performed on an automated cell analyzer
(FACSCalibur Cell Analyzer; BD Biosciencs).
Methylation analysis
Retroviral preparation and transduction was performed
as described previously [19]. For analysis of Mo-
MLV
40bp/GFP, bisulfite conversion using the method
described by Hajkova and colleagues [35] was used.
For Oct4 promoter analysis, DNA was converted using
a commercial kit (EZ DNA Methylation Gold™Kit;
Zymo Research Corp., Orange, CA, USA). Analysis and
statistical comparison of bisulfite data was performed
using QUMA software http://quma.cdb.riken.jp/[36].
For methylation-sensitive Southern blots, DNA was
subjected to 2 rounds of digestion with either methyla-
tion-sensitive HpaII or the methylation-insensitive iso-
schizomer MspI (New England Biolabs Inc., Ipswich,
MA, USA) to ensure complete digestion. Briefly, DNA
was purified from cell pellets (fresh or frozen) using a
commercial kit (DNeasy Kit; Qiagen) according to the
manufacturer’s protocol and quantified, before digest-
ing using a 10-fold unit excess of enzyme. After diges-
tion, DNA was precipitated with ethanol and digested
a second time. Digestions were performed for between
4 and 6 hours. Digested DNA was resolved in 1% agar-
ose gels, before being transferred onto a nylon mem-
brane. After ultraviolet-induced cross-linking,
membranes were incubated at 65°C with prehybridiza-
tion solution (6 × saline sodium citrate buffer, 10 ×
Denhardt solution, 1% sodium dodecyl sulfate, 10%
dextran sulfate). LINE1 and Intracisternal A Particle
(IAP) probes were used as described previously [37].
The minor satellite probe used has also been described
previously [38]. Probes were incubated with mem-
branes overnight, before washing and exposure to
phosphor screens (Phosphorimager; Molecular
D y n a m i c s ,S u n n y v a l e ,C A ,U S A ) .
Statistical analysis
All statistical comparisons were carried out using the
non-parametric two-tailed Mann-Whitney test.
Antibodies
For western blotting, the antibodies used were:
a n t i - D N M T 1r a b b i tp o l y c l o n a l( p A T H 5 2 )[ 3 7 ]1 :8 0 0 ;
anti-DNMT3A (SC-20703; Santa Cruz Biotechnologies,
Santa Cruz, CA, USA) 1:100; anti-DNMT3B (SC-52922;
Santa Cruz Biotechnologies) 1: 200; anti-tubulin mouse
monoclonal (T6199; Sigma Chemical Co. St. Louis, MO,
USA,); anti-UPF1 Rent1 (H300) (SC-48802; Santa Cruz
Biotechnologies), anti-FLAG M2, mouse monoclonal
(F3165; Sigma Chemical Co.) 1: 400. Horse radish-
conjugated secondary antibodies were obtained from
Sigma Chemical Co. IR-800 antibodies used for the
Li-Cor detection system were obtained from Rockland
Immunochemicals (Gilbertsville, PA, USA).
Primer sequences
Primers used for bisulfite analysis were designed using
MethPrimer [39]. The primer sets used are set out in
Table 1
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